罕见的恶性卵巢瘤:一篇评论
1Department of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Japanese journal of clinical oncology
|January 29, 2025
概括
本综述涵盖了三种罕见的卵巢瘤:中状腺癌,成年粒状细胞瘤和恶性瘤. 这些罕见的卵巢癌的预后不好,需要进一步研究有效的治疗方法.
科学领域:
- 妇科瘤学 妇科瘤学
- 病理学 病理学 病理学
- 罕见的卵巢瘤
背景情况:
- 卵巢恶性瘤包括各种组织学类型,罕见的亚型往往呈现出不良的预后.
- 了解罕见的卵巢瘤的特征对于改善患者的治疗结果至关重要.
- 本综述侧重于三种特定的罕见卵巢瘤类型:卵巢中状腺癌,成年粒状细胞瘤和成熟的瘤的恶性转变.
研究的目的:
- 综述和总结三个罕见的卵巢瘤类型的关键特征,预后和当前理解.
- 突出与这些罕见恶性瘤相关的诊断特征和挑战.
- 强调需要进一步的研究和潜在的治疗进展.
主要方法:
- 对罕见的卵巢瘤类型的文献综述.
- 对卵巢中类似腺癌的组织学,免疫组织化学和临床数据的分析.
- 对成年粒状细胞瘤和恶性瘤的治疗疗效和预后的总结.
主要成果:
- 卵巢中类似腺癌 (MLA) 是一种与子宫内膜异位症相关的侵袭性瘤,其特征是特定的免疫组织化学标记 (TTF-1,GATA3,PAX2,CD10阳性;ER/PR阴性) 和频繁的复发.
- 成人粒状细胞瘤虽然惰,但由于复发风险,需要作为主要治疗方法进行脱皮手术,晚期复发很常见.
- 成熟瘤的恶性转变,通常是状细胞癌,在晚期具有非常糟糕的预后,需要量身定制的治疗.
结论:
- 罕见的卵巢瘤,如MLA,成年粒状细胞瘤和恶性瘤,由于其不良预后和有限的研究数据,存在重大诊断和治疗挑战.
- 早期诊断和量身定制的治疗策略对于管理这些罕见的妇科恶性瘤至关重要.
- 药物治疗的进步为开发更有效的治疗方法提供了希望,用于这些具有挑战性的卵巢癌.
相关概念视频
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...